Subscribe Now Subscribe Today
Science Alert
Curve Top
Pakistan Journal of Biological Sciences
  Year: 2010 | Volume: 13 | Issue: 4 | Page No.: 175-179
DOI: 10.3923/pjbs.2010.175.179
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Comparison of Bone Scan with Carbohydrate Antigen 15-3 for Evaluation of Bone Metastasis of Brest Cancer

M. Mohammadzadeh, H. Alikhah and A.G.A. Zareh

This study aimed at comparing the bone scan and CA15-3 titer in patients with breast cancer for evaluation of bone metastasis. Thirty five patients with definite diagnosis of breast cancer were evaluated in Tabriz Imam Khomeini Hospital from 2007 to 2008. Bone scan (99 mTc-MDP) performed in all patients. The serum CA15-3 was measured by ECLIA method. The increased level was considered as >30 U mL-1. The serum level of CA15-3 was compared between the patients with and without bone metastasis, as well as its correlation with the extent of bone involvement. Thirty five patients with the mean age of 51.69±10.77 (34-81) years were enrolled in the study. According to bone scan results, 24 (68.8%) patients revealed bone metastasis. The mean level of serum CA15-3 was significantly higher in patents with bone metastasis than patients without metastasis (26.37±4.74 U mL-1 vs. 19.09±1.99 U mL-1; p<0.001). There was not significant relation between the serum level of CA15-3 and the extent of bone metastasis (rho = -0.063, p = 0.769). Coordinates of the curve study yielded a cut-off point > 21.8 U mL-1 for the serum level of CA15-3 in our patients, with a sensitivity and specificity of 91.7 and 91%, respectively. Serum level of CA15-3 is higher in the patients with bone metastatic breast cancer; however, the recommended cut-off point might not be suitable for Iranian patients. Further studies with large sample sizes are recommended.
PDF Fulltext XML References Citation Report Citation
  •    Expression of Epidermal Growth Factor Receptor Tyrosine Kinase Family in Fine Needle Aspiration and Permanent Specimens of Invasive Lobular and Ductal Breast Cancers
  •    The Use of Carbohydrate Antigen (CA) 15-3 as a Tumor Marker in Detecting Breast Cancer
How to cite this article:

M. Mohammadzadeh, H. Alikhah and A.G.A. Zareh, 2010. Comparison of Bone Scan with Carbohydrate Antigen 15-3 for Evaluation of Bone Metastasis of Brest Cancer. Pakistan Journal of Biological Sciences, 13: 175-179.

DOI: 10.3923/pjbs.2010.175.179






Curve Bottom